Key Takeaways DOCS is considered better positioned than peers as AI adoption accelerates across medical technology. DOCS embeds AI across workflows, boosted by a Pathway acquisition and industry-leading EBITDA and cash flow. TEM is expanding AI diagnostics, winning FDA clearances, and reached positive adjusted EBITDA in Q3 2025. Advancements in artificial intelligence (AI) within the medical technology industry are playing a significant role in improving patient lives by enabling innovative care delivery, r ...